SNYR
Synergy CHC Corp.
Company overview
- Market capitalization
- —
- Employees
- 28
- Latest publication
- 2026-09-29
About Synergy CHC Corp.
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; Neuragen a homeopathic product; and UrgentRx, an over the counter drug. It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. The company was incorporated in 2010 and is based in Windham, Maine.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,492,705USD | 6,065,167USD | 8,010,111USD | 8,134,996USD | 8,170,534USD | 10,271,207USD | 7,126,333USD | 8,024,840USD |
| Cost Of Revenue | 1,555,243USD | 3,845,791USD | 2,362,629USD | 1,896,391USD | 2,006,513USD | 3,769,294USD | 2,335,901USD | 2,448,890USD |
| Gross Profit | 3,937,462USD | 2,219,376USD | 5,647,483USD | 6,238,605USD | 6,164,021USD | 6,501,913USD | 4,790,432USD | 5,575,950USD |
| Selling General Administrative | 2,048,850USD | 8,835,588USD | 1,637,706USD | 1,519,325USD | 1,306,714USD | 1,267,999USD | 1,196,784USD | 903,838USD |
| Selling And Marketing Expenses | 2,455,732USD | — | 2,729,767USD | 3,062,211USD | 2,876,271USD | 3,842,128USD | 2,509,440USD | 3,055,186USD |
| Total Operating Expenses | 4,504,582USD | 12,714,713USD | 4,367,473USD | 4,614,870USD | 4,216,318USD | 5,143,461USD | 3,739,557USD | 3,992,358USD |
| Operating Income | -567,120USD | -6,649,546USD | 1,280,010USD | 1,623,735USD | 1,947,703USD | 1,358,452USD | 1,050,875USD | 1,583,592USD |
| Interest Income | 340USD | — | — | 379USD | 13,882USD | — | — | 374USD |
| Interest Expense | 2,012,121USD | 1,566,902USD | 1,164,017USD | 2,107,714USD | 1,095,369USD | 1,545,744USD | 704,707USD | 745,528USD |
| Net Interest Income | -2,011,781USD | -1,551,837USD | -1,164,017USD | -2,107,335USD | -1,081,487USD | -1,544,221USD | -704,707USD | -745,154USD |
| Income Before Tax | -2,582,619USD | -14,866,104USD | 114,220USD | 1,663,344USD | 864,804USD | 93,480USD | 591,294USD | 834,568USD |
| Income Tax Expense | -13,720USD | — | -11,107USD | 190,107USD | -11,460USD | -12,187USD | -192,299USD | 179,382USD |
| Tax Provision | -13,720USD | -50,069USD | -11,107USD | 190,107USD | -11,460USD | -12,187USD | -192,299USD | 179,382USD |
| Net Income | -2,568,899USD | -14,816,035USD | 125,327USD | 1,473,237USD | 876,264USD | 105,667USD | 783,593USD | 655,186USD |
| Net Income From Continuing Ops | -2,568,899USD | -14,816,035USD | 125,327USD | 1,473,237USD | 876,264USD | 105,667USD | 783,593USD | 655,186USD |
| Ebit | -567,120USD | — | 1,278,237USD | 3,771,058USD | 1,960,173USD | 1,639,224USD | 1,296,001USD | 1,580,096USD |
| Ebitda | -533,787USD | — | 1,311,570USD | 3,804,392USD | 1,993,506USD | 1,672,558USD | 1,329,334USD | 1,613,430USD |
| Depreciation And Amortization | 33,333USD | — | 33,333USD | 33,334USD | 33,333USD | 33,334USD | 33,333USD | 33,334USD |
| Reconciled Depreciation | 33,333USD | 33,334USD | 33,333USD | 33,334USD | 33,333USD | 33,334USD | 33,333USD | 33,333USD |
| Total Other Income Expense Net | -2,015,499USD | -6,664,721USD | -1,165,790USD | 39,609USD | -1,082,899USD | -1,264,972USD | -459,581USD | -749,024USD |
| Unclassified Operating Expenses | — | 3,879,125USD | — | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 30,380,809USD | 34,834,243USD | 42,777,633USD | 38,410,674USD | — | 40,226,865USD | 29,357,546USD | 33,824,495USD |
| Cost Of Revenue | 10,077,992USD | 11,191,224USD | 10,697,323USD | 25,452,988USD | — | 14,679,130USD | 9,137,602USD | 12,474,098USD |
| Gross Profit | 20,302,817USD | 23,643,019USD | 32,080,310USD | 12,957,686USD | — | 25,547,735USD | 20,219,944USD | 21,350,397USD |
| Selling General Administrative | 8,829,803USD | 4,717,006USD | 6,051,703USD | 9,197,068USD | — | 6,499,344USD | 5,493,433USD | 7,191,646USD |
| Selling And Marketing Expenses | 13,137,779USD | 12,991,431USD | 15,188,528USD | 28,504,524USD | — | 15,889,066USD | 11,471,652USD | 16,330,365USD |
| Total Operating Expenses | 22,100,916USD | 17,841,771USD | 21,273,564USD | 37,923,949USD | — | 22,462,478USD | 28,176,054USD | 25,344,075USD |
| Operating Income | -1,798,099USD | 5,801,248USD | 10,806,746USD | -24,966,263USD | — | 3,085,260USD | -7,956,110USD | -4,917,746USD |
| Interest Income | 15,065USD | 1,523USD | 1,616USD | — | — | — | 414USD | 235USD |
| Interest Expense | 5,919,742USD | 4,105,198USD | 4,236,149USD | 6,450,365USD | — | 1,295,466USD | 1,111,934USD | 1,132,763USD |
| Net Interest Income | -5,904,677USD | -4,103,675USD | -4,234,533USD | — | — | — | -1,111,520USD | -1,346,494USD |
| Income Before Tax | -12,223,737USD | 2,227,061USD | 6,573,730USD | -32,599,116USD | — | 1,411,132USD | -9,075,910USD | -6,408,384USD |
| Income Tax Expense | 117,471USD | 102,085USD | 234,980USD | 32,172USD | — | -5USD | 131,537USD | -247,694USD |
| Tax Provision | 117,471USD | 102,085USD | 234,980USD | — | — | — | 131,537USD | -247,694USD |
| Net Income | -12,341,208USD | 2,124,976USD | 6,338,750USD | -32,631,287USD | — | 1,411,132USD | -9,207,447USD | -6,160,690USD |
| Net Income From Continuing Ops | -12,341,208USD | 2,124,976USD | 6,338,750USD | — | — | — | -9,207,447USD | -6,160,690USD |
| Ebit | -6,303,995USD | 6,332,259USD | 10,809,879USD | -26,148,751USD | — | 2,706,599USD | -8,094,804USD | -4,179,615USD |
| Ebitda | -6,170,661USD | 6,465,593USD | 10,843,212USD | -25,808,751USD | — | 2,806,864USD | -6,882,944USD | -2,357,551USD |
| Depreciation And Amortization | 133,334USD | 133,334USD | 33,333USD | 340,000USD | 236,558USD | 100,265USD | 1,211,860USD | 1,822,064USD |
| Reconciled Depreciation | 133,334USD | 133,334USD | 33,333USD | — | — | — | 1,211,860USD | 1,822,064USD |
| Total Other Income Expense Net | -10,425,638USD | -3,574,187USD | -4,233,016USD | -7,632,853USD | — | -1,674,128USD | -1,119,800USD | -1,490,638USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | 1,411,132USD | -9,207,447USD | -6,160,690USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | 11,210,969USD | 1,822,064USD |
| Research Development | — | — | — | — | — | — | — | 0USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 0USD |
| Minority Interest | — | — | — | — | — | — | — | 0USD |
| Discontinued Operations | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 6,461,591USD | 10,164,376USD | 20,690,952USD | 19,726,346USD | 15,656,042USD | 16,343,101USD | 12,169,953USD | 11,223,698USD |
| Intangible Assets | 116,667USD | 150,000USD | 183,333USD | 216,667USD | 250,000USD | 283,333USD | 316,667USD | 350,000USD |
| Other Current Assets | 1,403,173USD | — | 3,852,311USD | 2,164,094USD | 2,270,263USD | 1,959,563USD | 1,172,639USD | 1,073,482USD |
| Total Liab | 31,866,841USD | 33,292,514USD | 28,943,299USD | 32,105,546USD | 31,295,408USD | 32,974,444USD | 37,339,045USD | 37,101,971USD |
| Total Stockholder Equity | -25,405,250USD | -23,128,138USD | -8,252,347USD | -12,379,200USD | -15,639,366USD | -16,631,343USD | -25,169,092USD | -25,878,273USD |
| Other Current Liab | 1,091,011USD | 2USD | 1,496,114USD | 4,415,011USD | 2,426,265USD | 4,423,583USD | 5,082,140USD | 4,053,378USD |
| Common Stock | 114USD | — | 114USD | 96USD | 88USD | 87USD | 76USD | 76USD |
| Capital Stock | 114USD | 114USD | 114USD | 96USD | 88USD | 87USD | 76USD | — |
| Retained Earnings | -59,009,920USD | -56,441,021USD | -41,624,985USD | -41,750,312USD | -43,223,549USD | -44,099,813USD | -44,332,980USD | -45,116,573USD |
| Cash | 292,115USD | 2,622,313USD | 1,106,489USD | 1,458,561USD | 177,882USD | 687,920USD | 259,375USD | 187,293USD |
| Cash And Short Term Investments | 292,115USD | — | 1,106,489USD | 1,458,561USD | 177,882USD | 687,920USD | 259,375USD | 187,293USD |
| Total Current Assets | 6,344,924USD | 10,014,376USD | 20,507,619USD | 19,509,679USD | 15,406,042USD | 16,059,768USD | 11,853,286USD | 10,873,698USD |
| Total Current Liabilities | 6,848,786USD | 8,236,068USD | 3,830,122USD | 7,126,547USD | 8,065,745USD | 17,184,369USD | 18,248,970USD | 14,711,896USD |
| Net Debt | 27,456,921USD | 24,192,348USD | 24,006,688USD | 25,415,295USD | 27,941,336USD | 26,827,427USD | 31,741,158USD | 31,271,606USD |
| Short Term Debt | 2,730,981USD | — | — | 1,894,857USD | 4,889,555USD | 11,725,272USD | 12,910,458USD | 9,068,824USD |
| Short Long Term Debt | 2,730,981USD | 1,758,215USD | — | 1,894,857USD | 4,889,555USD | 11,725,272USD | 12,910,458USD | — |
| Short Long Term Debt Total | 27,749,036USD | — | 25,113,177USD | 26,873,856USD | 28,119,218USD | 27,515,347USD | 32,000,533USD | 31,458,899USD |
| Long Term Debt | 25,018,055USD | 25,056,446USD | 25,113,177USD | 24,978,999USD | 23,229,663USD | 15,790,075USD | 19,090,075USD | — |
| Net Receivables | 1,268,022USD | 3,203,505USD | 13,402,853USD | 13,522,866USD | 10,611,410USD | 11,695,733USD | 8,510,757USD | 7,692,633USD |
| Inventory | 3,381,614USD | 3,737,509USD | 2,145,966USD | 2,364,158USD | 2,346,487USD | 1,716,552USD | 1,910,515USD | 1,920,290USD |
| Accounts Payable | 2,940,983USD | — | 2,332,154USD | — | — | — | — | 1,578,441USD |
| Accumulated Other Comprehensive Income | 21,198USD | — | -35,915USD | -9,838USD | -49,712USD | -47,777USD | 5,881USD | 84,906USD |
| Common Stock Shares Outstanding | 11,303,853shares | 11,303,853shares | 10,111,134shares | 8,928,548shares | 8,577,620shares | 7,630,501shares | 7,553,818shares | 7,508,800shares |
| Non Current Assets Total | 116,667USD | 150,000USD | 183,333USD | 216,667USD | 250,000USD | 283,333USD | 316,667USD | 350,000USD |
| Non Current Liabilities Total | 25,018,055USD | 25,056,446USD | 25,113,177USD | 24,978,999USD | 23,229,663USD | 15,790,075USD | 19,090,075USD | 22,390,075USD |
| Net Working Capital | -503,862USD | 1,778,308USD | 16,677,497USD | 12,383,132USD | 7,340,297USD | -1,124,601USD | -6,395,684USD | — |
| Unclassified Current Liabilities | -2,645,170USD | 6,477,851USD | — | -1,083,065USD | -4,139,666USD | -10,714,010USD | -12,656,186USD | — |
| Unclassified Equity | 33,583,244USD | 33,312,769USD | 33,408,325USD | 29,380,758USD | 27,633,719USD | 27,516,073USD | 19,157,855USD | 19,153,318USD |
| Current Deferred Revenue | — | — | 1,854USD | 4,887USD | 36USD | 24,252USD | 2,100USD | 11,253USD |
| Good Will | — | — | — | — | — | 283,332,716,667USD | — | — |
| Unclassified Non Current Assets | — | — | — | — | — | -283,332,716,667USD | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | — | 22,390,075USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 10,164,376USD | 16,343,101USD | 12,239,516USD | 18,541,733USD | — | 12,587,089USD | 5,190,629USD | 20,010,511USD |
| Intangible Assets | 150,000USD | 283,333USD | 416,667USD | — | — | — | 7,636USD | 3,007,521USD |
| Other Current Assets | 451,049USD | 1,959,563USD | 897,985USD | 739,769USD | — | 874,920USD | 286,143USD | 965,027USD |
| Total Liab | 33,292,514USD | 32,974,444USD | 39,545,489USD | 52,061,600USD | — | 16,271,192USD | 10,393,980USD | 16,039,818USD |
| Total Stockholder Equity | -23,128,138USD | -16,631,343USD | -27,305,973USD | -33,519,866USD | — | -3,684,103USD | -5,203,351USD | 3,970,693USD |
| Other Current Liab | 6,389,745USD | 5,191,868USD | 10,838,079USD | 9,639,745USD | — | 7,079,984USD | 4,242,238USD | 7,783,487USD |
| Common Stock | 114USD | 87USD | 76USD | 899USD | — | 899USD | 899USD | 899USD |
| Capital Stock | 114USD | 87USD | 76USD | — | — | — | 899USD | 899USD |
| Retained Earnings | -56,441,021USD | -44,099,813USD | -46,224,789USD | -52,691,039USD | — | -22,823,437USD | -24,234,569USD | -15,027,122USD |
| Cash | 2,622,313USD | 687,920USD | 632,534USD | 1,926,443USD | — | 1,665,453USD | 1,224,514USD | 459,736USD |
| Cash And Short Term Investments | 2,622,313USD | 687,920USD | 632,534USD | 1,926,443USD | — | 1,665,453USD | 1,224,514USD | 459,736USD |
| Total Current Assets | 10,014,376USD | 16,059,768USD | 11,822,849USD | 18,541,733USD | — | 12,587,089USD | 5,047,095USD | 8,939,979USD |
| Total Current Liabilities | 8,236,068USD | 17,184,369USD | 14,021,882USD | 30,262,522USD | — | 14,739,196USD | 10,147,064USD | 10,410,816USD |
| Net Debt | 24,192,348USD | 26,827,427USD | 26,985,598USD | 20,899,088USD | — | 7,081,463USD | 4,488,650USD | 7,311,978USD |
| Short Term Debt | 1,758,215USD | 11,725,272USD | 2,094,525USD | 1,026,453USD | — | 7,515,693USD | 5,466,248USD | 2,142,712USD |
| Short Long Term Debt | 1,758,215USD | 11,725,272USD | 2,094,525USD | — | — | — | 5,466,248USD | 2,142,712USD |
| Short Long Term Debt Total | 26,814,661USD | 27,515,347USD | 27,618,132USD | 22,825,531USD | — | 8,746,916USD | 5,713,164USD | 7,771,714USD |
| Long Term Debt | 25,056,446USD | 15,790,075USD | 25,523,607USD | — | — | — | 246,916USD | 5,629,002USD |
| Net Receivables | 3,203,505USD | 11,695,733USD | 6,566,090USD | 7,907,804USD | — | 6,217,960USD | 1,675,400USD | 4,844,911USD |
| Inventory | 3,737,509USD | 1,716,552USD | 3,726,240USD | 7,967,717USD | — | 3,828,756USD | 1,861,038USD | 2,670,305USD |
| Accumulated Other Comprehensive Income | -154,281USD | -47,777USD | -102,467USD | 22,389USD | — | -9,449USD | 11,364USD | 179,116USD |
| Common Stock Shares Outstanding | 9,722,552shares | 7,630,501shares | 89,889,074shares | 89,889,074shares | 89,889,074shares | 89,889,044shares | 89,883,194shares | 89,862,683shares |
| Non Current Assets Total | 150,000USD | 283,333USD | 416,667USD | — | — | — | 143,534USD | 11,070,532USD |
| Non Current Liabilities Total | 25,056,446USD | 15,790,075USD | 25,523,607USD | 21,799,078USD | — | 1,531,995USD | 246,916USD | 5,629,002USD |
| Net Working Capital | 1,778,308USD | -1,124,601USD | -2,199,033USD | — | — | — | -5,099,969USD | -1,470,837USD |
| Unclassified Current Liabilities | -1,670,107USD | -11,482,295USD | -1,069,421USD | — | — | — | -5,061,763USD | -1,784,421USD |
| Unclassified Equity | 33,466,936USD | 27,516,073USD | 19,021,131USD | 19,147,885USD | — | 19,147,884USD | 19,018,056USD | 18,816,901USD |
| Current Deferred Revenue | — | 24,252USD | 14,202USD | — | — | 121,803USD | 7,887USD | 49,709USD |
| Accounts Payable | — | — | 49,972USD | 19,596,324USD | — | 21,716USD | 26,206USD | 76,617USD |
| Unclassified Non Current Liabilities | — | — | — | 21,799,078USD | — | 1,231,222USD | — | — |
| Other Liab | — | — | — | — | — | 300,773USD | — | 0USD |
| Net Tangible Assets | — | — | — | — | — | -3,684,103USD | -5,210,987USD | -6,830,068USD |
| Good Will | — | — | — | — | — | — | 0USD | 7,793,240USD |
| Other Assets | — | — | — | — | — | — | 0USD | 0USD |
| Property Plant Equipment Net | — | — | — | — | — | — | 135,898USD | 269,771USD |
| Property Plant Equipment Gross | — | — | — | — | — | — | 566,445USD | 0USD |
| Non Currrent Assets Other | — | — | — | — | — | — | 0USD | 11,070,532USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 0USD |
| Long Term Investments | — | — | — | — | — | — | — | 0USD |
| Short Term Investments | — | — | — | — | — | — | — | 0USD |
| Accumulated Depreciation | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Non Current Liabilities Other | — | — | — | — | — | — | — | 0USD |
| Unclassified Non Current Assets | — | — | — | — | — | — | — | -11,070,532USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -2,568,899USD | -14,816,040USD | 125,327USD | 1,473,237USD | 876,264USD | 105,667USD | 783,593USD | 655,186USD |
| Depreciation | 33,333USD | 33,334USD | 33,333USD | 33,334USD | 33,333USD | 33,334USD | 33,333USD | 33,333USD |
| Stock Based Compensation | -19,940,864,000USD | 116,306USD | 19,941USD | 0USD | 0USD | — | 4,613USD | — |
| Other Non Cash Items | 1,074,651USD | 2,761,827USD | 399,996USD | -817,395USD | 402,292USD | -277,773USD | 55,231USD | 18,247USD |
| Change To Account Receivables | 1,935,483USD | 3,006,547USD | 120,013USD | -2,911,456USD | 1,084,323USD | -2,674,442USD | -818,124USD | -833,375USD |
| Change To Inventory | 355,895USD | -2,485,884USD | 218,192USD | -17,671USD | -629,935USD | 68,599USD | 9,775USD | 789,495USD |
| Change In Working Capital | -583,763USD | 7,226,604USD | -2,868,074USD | -766,126USD | -2,134,670USD | -3,287,139USD | -1,114,244USD | -988,729USD |
| Total Cash From Operating Activities | -2,044,678USD | 624,127USD | -2,309,418USD | -76,950USD | -822,781USD | -3,425,911USD | -237,474USD | -281,963USD |
| Capital Expenditures | -2USD | 0USD | -2USD | 0USD | 0USD | -1USD | -5USD | 0USD |
| Free Cash Flow | -2,044,680USD | 624,127USD | -2,309,418USD | -76,950USD | -822,781USD | -3,425,910USD | -237,474USD | -281,963USD |
| Net Borrowings | -252,600USD | 1,213,057USD | -1,832,000USD | 3,298,669USD | 179,678USD | -1,578,771USD | -1,240,355USD | — |
| Total Cash From Financing Activities | -307,600USD | 1,138,808USD | 1,883,423USD | 1,317,755USD | 314,678USD | 3,908,114USD | 488,581USD | -597,229USD |
| Change In Cash | -2,330,198USD | 1,615,824USD | -452,072USD | 1,280,679USD | -510,038USD | 428,545USD | 172,082USD | -823,456USD |
| Begin Period Cash Flow | 2,722,313USD | 1,106,489USD | 1,558,561USD | 277,882USD | 787,920USD | 359,375USD | 187,293USD | 1,010,749USD |
| End Period Cash Flow | 392,115USD | 2,722,313USD | 1,106,489USD | 1,558,561USD | 277,882USD | 787,920USD | 359,375USD | 187,293USD |
| Other Cashflows From Financing Activities | 86,666USD | — | -135,000USD | -1,980,914USD | 135,000USD | -2,910,159USD | 1,728,936USD | 109,226USD |
| Unclassified Operating Cash Flow | 19,940,864,000USD | 5,302,096USD | — | — | — | — | — | — |
| Issuance Of Capital Stock | — | -160,915USD | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | 3,850,423USD | — | — | 8,397,044USD | — | — |
| Investments | — | — | — | — | 0USD | 0USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -12,341,208USD | 2,124,976USD | 6,338,750USD | -32,631,287USD | — | 1,411,132USD | -9,207,447USD | -6,160,690USD |
| Depreciation | 1,633,776USD | 133,334USD | 33,333USD | 340,000USD | — | 100,265USD | 1,211,860USD | 1,822,064USD |
| Stock Based Compensation | 136,247USD | 0USD | — | — | — | 128,928USD | 201,155USD | 441,000USD |
| Other Non Cash Items | 6,528,429USD | -190,288USD | -4,330,413USD | 17,255,476USD | — | 1,338,094USD | 453,111USD | 351,724USD |
| Change To Account Receivables | 1,860,323USD | -4,619,109USD | 1,341,714USD | 1,415,221USD | — | -4,378,860USD | 2,750,468USD | -193,687USD |
| Change To Inventory | -2,915,298USD | 1,884,324USD | 3,990,456USD | -7,464,832USD | — | -2,133,145USD | 552,158USD | -884,141USD |
| Change In Working Capital | 1,457,734USD | -6,871,412USD | -1,619,941USD | 6,604,372USD | — | -4,437,739USD | 308,451USD | 2,566,453USD |
| Total Cash From Operating Activities | -2,585,022USD | -4,803,390USD | 421,729USD | -8,431,439USD | — | -1,588,248USD | 2,946,350USD | 1,304,632USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -1USD | 0USD | -2USD | 0USD | -198,007USD |
| Free Cash Flow | -2,585,022USD | -4,803,390USD | 421,729USD | -8,431,440USD | — | -1,588,250USD | 2,946,350USD | 1,106,625USD |
| Net Borrowings | 2,859,404USD | -3,920,961USD | -2,090,782USD | — | — | 1,950,000USD | -2,050,000USD | -2,862,500USD |
| Total Cash From Financing Activities | 4,654,664USD | 4,804,086USD | -2,090,782USD | 8,963,301USD | — | 1,950,000USD | -2,050,000USD | -2,862,500USD |
| Issuance Of Capital Stock | 3,719,547USD | 8,397,044USD | 0USD | — | — | — | — | 0USD |
| Change In Cash | 1,934,393USD | 55,386USD | -1,793,909USD | 860,990USD | — | 340,939USD | 728,598USD | -1,498,769USD |
| Begin Period Cash Flow | 787,920USD | 732,534USD | 2,526,443USD | 1,665,453USD | 1,665,453USD | 1,324,514USD | 595,916USD | 2,094,685USD |
| End Period Cash Flow | 2,722,313USD | 787,920USD | 732,534USD | 2,526,443USD | 1,665,453USD | 1,665,453USD | 1,324,514USD | 595,916USD |
| Other Cashflows From Financing Activities | -1,924,287USD | 328,003USD | -2,090,782USD | 500USD | — | 1,950,000USD | — | -198,007USD |
| Investments | — | 0USD | 0USD | — | — | — | 0USD | -198,007USD |
| Unclassified Financing Cash Flow | — | — | 2,090,782USD | 8,962,801USD | — | -1,950,000USD | — | — |
| Change To Liabilities | — | — | — | — | — | 2,824,580USD | -3,771,951USD | 3,329,877USD |
| Total Cashflows From Investing Activities | — | — | — | — | — | -361,390USD | — | -198,007USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | -361,390USD | — | -69USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | 9,979,220USD | 2,284,081USD |
| Dividends Paid | — | — | — | — | — | — | — | 0USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | — | 0USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | 0USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | Canada | 227,580 | USD | 0001213900-26-056237 |
| Q1 2026Quarterly · 2026-03-31 | Geography | MX | 42,831 | USD | 0001213900-26-056237 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Other | 414 | USD | 0001213900-26-056237 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 5,221,880 | USD | 0001213900-26-056237 |
| Q1 2026Quarterly · 2026-03-31 | Product | Online | 1,787,085 | USD | 0001213900-26-056237 |
| Q1 2026Quarterly · 2026-03-31 | Product | Retail | 3,705,620 | USD | 0001213900-26-056237 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Beverages | 667,942 | USD | 0001213900-26-056237 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Nutraceuticals | 4,824,763 | USD | 0001213900-26-056237 |
| FY 2025Yearly · 2025-12-31 | Geography | Canada | 2,418,056 | USD | 0001213900-26-037883 |
| FY 2025Yearly · 2025-12-31 | Geography | MX | 623,660 | USD | 0001213900-26-037883 |
| FY 2025Yearly · 2025-12-31 | Geography | Other | 20,716 | USD | 0001213900-26-037883 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 27,318,377 | USD | 0001213900-26-037883 |
| FY 2025Yearly · 2025-12-31 | Segment | Beverages | 631,332 | USD | 0001213900-26-037883 |
| FY 2025Yearly · 2025-12-31 | Segment | Consumer Goods | 17,987 | USD | 0001213900-26-037883 |
| FY 2025Yearly · 2025-12-31 | Segment | Nutraceuticals | 29,731,664 | USD | 0001213900-26-037883 |
| Q3 2025Quarterly · 2025-09-30 | Geography | International | 932,464 | USD | 0001213900-25-109587 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 7,077,648 | USD | 0001213900-25-109587 |
| Q3 2025Quarterly · 2025-09-30 | Product | Nutraceuticals — Online | 2,210,175 | USD | 0001213900-25-109587 |
| Q3 2025Quarterly · 2025-09-30 | Product | Nutraceuticals — Retailer Promotions | 5,799,937 | USD | 0001213900-25-109587 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Foreign Countries | 180,670 | USD | 0001213900-25-076060 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 7,954,326 | USD | 0001213900-25-076060 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Canada | 656,877 | USD | 0001213900-26-056237 |
| Q1 2025Quarterly · 2025-03-31 | Geography | MX | 1,320 | USD | 0001213900-26-056237 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Other | 57,613 | USD | 0001213900-26-056237 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 7,454,724 | USD | 0001213900-26-056237 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Beverages | 30,970 | USD | 0001213900-26-056237 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Consumer Goods | 1,500,000 | USD | 0001213900-26-056237 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Nutraceuticals | 6,639,564 | USD | 0001213900-26-056237 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Foreign Countries | 832,284 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 9,438,923 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Canada | 3,926,370 | USD | 0001213900-26-037883 |
| FY 2024Yearly · 2024-12-31 | Geography | MX | 3,638 | USD | 0001213900-26-037883 |
| FY 2024Yearly · 2024-12-31 | Geography | Other | 73,047 | USD | 0001213900-26-037883 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 30,831,188 | USD | 0001213900-26-037883 |
| FY 2024Yearly · 2024-12-31 | Segment | Beverages | 1,425,239 | USD | 0001213900-26-037883 |
| FY 2024Yearly · 2024-12-31 | Segment | Consumer Goods | 16,910 | USD | 0001213900-26-037883 |
| FY 2024Yearly · 2024-12-31 | Segment | Nutraceuticals | 33,392,094 | USD | 0001213900-26-037883 |
| FY 2024Yearly · 2024-12-31 | Product | Online | 8,360,297 | USD | 0001213900-26-037883 |
| FY 2024Yearly · 2024-12-31 | Product | Retail | 26,473,946 | USD | 0001213900-26-037883 |
| Q3 2024Quarterly · 2024-09-30 | Geography | International | 718,160 | USD | 0001213900-25-109587 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 6,408,173 | USD | 0001213900-25-109587 |
| Q3 2024Quarterly · 2024-09-30 | Product | Nutraceuticals — Online | 1,374,610 | USD | 0001213900-25-109587 |
| Q3 2024Quarterly · 2024-09-30 | Product | Nutraceuticals — Retailer Promotions | 5,751,723 | USD | 0001213900-25-109587 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Foreign Countries | 1,319,354 | USD | 0001213900-25-076060 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 6,705,486 | USD | 0001213900-25-076060 |
| Q2 2024Quarterly · 2024-06-30 | Product | Nutraceuticals — Online | 979,540 | USD | 0001213900-25-076060 |
| Q2 2024Quarterly · 2024-06-30 | Product | Nutraceuticals — Retailer Promotions | 7,045,300 | USD | 0001213900-25-076060 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Foreign Countries | 1,133,257 | USD | 0001213900-25-043703 |
| Q1 2024Quarterly · 2024-03-31 | Geography | United States | 8,278,606 | USD | 0001213900-25-043703 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product Sales — Online | 1,170,637 | USD | 0001213900-25-043703 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product Sales — Retail | 8,241,226 | USD | 0001213900-25-043703 |
| FY 2023Yearly · 2023-12-31 | Geography | Foreign Countries | 2,155,648 | USD | 0001213900-25-026254 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 40,621,985 | USD | 0001213900-25-026254 |
| FY 2023Yearly · 2023-12-31 | Segment | Consumer Goods | 24,581 | USD | 0001213900-25-026254 |
| FY 2023Yearly · 2023-12-31 | Segment | Nutraceuticals | 42,753,052 | USD | 0001213900-25-026254 |
| FY 2023Yearly · 2023-12-31 | Product | Online | 11,001,906 | USD | 0001213900-25-026254 |
| FY 2023Yearly · 2023-12-31 | Product | Retail | 31,775,727 | USD | 0001213900-25-026254 |
| Q3 2023Quarterly · 2023-09-30 | Product | Online | 2,198,251 | USD | 0001213900-24-106476 |
| Q3 2023Quarterly · 2023-09-30 | Product | Retail | 8,607,484 | USD | 0001213900-24-106476 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Consumer Goods | 6,199 | USD | 0001213900-24-106476 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Nutraceuticals | 10,799,536 | USD | 0001213900-24-106476 |
| Q1 2020Quarterly · 2020-03-31 | Product | Online | 2,671,221 | USD | 0001493152-20-012067 |
| Q1 2020Quarterly · 2020-03-31 | Product | Retail | 3,446,065 | USD | 0001493152-20-012067 |
| Q1 2020Quarterly · 2020-03-31 | Segment | Consumer Goods | 302,897 | USD | 0001493152-20-012067 |
| Q1 2020Quarterly · 2020-03-31 | Segment | Cosmeceuticals | 25,388 | USD | 0001493152-20-012067 |
| Q1 2020Quarterly · 2020-03-31 | Segment | Nutraceuticals | 5,766,691 | USD | 0001493152-20-012067 |
| Q1 2020Quarterly · 2020-03-31 | Segment | Over The Counter | 22,310 | USD | 0001493152-20-012067 |
| Q4 2019Quarterly · 2019-12-31 | Product | Online | 1,541,320 | USD | Legacy provider |
| Q4 2019Quarterly · 2019-12-31 | Product | Retail | 4,646,004 | USD | Legacy provider |
| Q4 2019Quarterly · 2019-12-31 | Segment | Consumer Goods | 129,934 | USD | Legacy provider |
| Q4 2019Quarterly · 2019-12-31 | Segment | Cosmeceuticals | 34,261 | USD | Legacy provider |
| Q4 2019Quarterly · 2019-12-31 | Segment | Nutraceuticals | 5,998,891 | USD | Legacy provider |
| Q4 2019Quarterly · 2019-12-31 | Segment | Over The Counter | 24,238 | USD | Legacy provider |
| FY 2019Yearly · 2019-12-31 | Geography | Foreign Countries | 2,062,420 | USD | 0001493152-20-007381 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 27,295,126 | USD | 0001493152-20-007381 |
| FY 2019Yearly · 2019-12-31 | Segment | Consumer Goods | 706,688 | USD | 0001493152-20-007381 |
| FY 2019Yearly · 2019-12-31 | Segment | Cosmeceuticals | 438,561 | USD | 0001493152-20-007381 |
| FY 2019Yearly · 2019-12-31 | Segment | Nutraceuticals | 28,149,938 | USD | 0001493152-20-007381 |
| FY 2019Yearly · 2019-12-31 | Segment | Over The Counter | 62,359 | USD | 0001493152-20-007381 |
| FY 2019Yearly · 2019-12-31 | Product | Online | 10,382,593 | USD | 0001493152-20-007381 |
| FY 2019Yearly · 2019-12-31 | Product | Retail | 18,974,953 | USD | 0001493152-20-007381 |
| Q3 2019Quarterly · 2019-09-30 | Segment | Consumer Goods | 224,724 | USD | 0001493152-19-017372 |
| Q3 2019Quarterly · 2019-09-30 | Segment | Cosmeceuticals | 36,556 | USD | 0001493152-19-017372 |
| Q3 2019Quarterly · 2019-09-30 | Segment | Nutraceuticals | 7,094,211 | USD | 0001493152-19-017372 |
| Q3 2019Quarterly · 2019-09-30 | Segment | Over The Counter | 9,055 | USD | 0001493152-19-017372 |
| Q2 2019Quarterly · 2019-06-30 | Segment | Consumer Goods | 194,407 | USD | 0001493152-19-012229 |
| Q2 2019Quarterly · 2019-06-30 | Segment | Cosmeceuticals | 120,188 | USD | 0001493152-19-012229 |
| Q2 2019Quarterly · 2019-06-30 | Segment | Nutraceuticals | 6,001,392 | USD | 0001493152-19-012229 |
| Q2 2019Quarterly · 2019-06-30 | Segment | Over The Counter | 20,734 | USD | 0001493152-19-012229 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Consumer Goods | 157,623 | USD | 0001493152-20-012067 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Cosmeceuticals | 247,556 | USD | 0001493152-20-012067 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Nutraceuticals | 9,055,444 | USD | 0001493152-20-012067 |
| Q1 2019Quarterly · 2019-03-31 | Segment | Over The Counter | 8,332 | USD | 0001493152-20-012067 |
| FY 2018Yearly · 2018-12-31 | Geography | Foreign Countries | 2,093,191 | USD | 0001493152-20-007381 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 31,731,304 | USD | 0001493152-20-007381 |
| FY 2018Yearly · 2018-12-31 | Segment | Consumer Goods | 987,230 | USD | 0001493152-20-007381 |
| FY 2018Yearly · 2018-12-31 | Segment | Cosmeceuticals | 1,076,442 | USD | 0001493152-20-007381 |
| FY 2018Yearly · 2018-12-31 | Segment | Nutraceuticals | 31,332,952 | USD | 0001493152-20-007381 |
| FY 2018Yearly · 2018-12-31 | Segment | Over The Counter | 427,871 | USD | 0001493152-20-007381 |
| FY 2018Yearly · 2018-12-31 | Product | Online | 16,156,081 | USD | 0001493152-20-007381 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.